Entera Bio Ltd.
Organization details
- Legal name
- Entera Bio Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Jerusalem
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- ENTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001638097
Board of directors
-
Geno J. Germano · DirectorSince 2026
-
Gerald M. Lieberman · DirectorSince 2023
-
Gerald M. Ostrov · DirectorSince 2023
-
Haya Taitel · DirectorSince 2023
-
Miranda Jayne Toledano · Director · Chief Executive OfficerSince 2023
-
Roger Garceau · DirectorSince 2023
-
Ron Mayron · DirectorSince 2023
-
Sean Ellis · DirectorSince 2023
- Since 2026
-
Yonatan Malca · DirectorSince 2023
Chief executives
Director election results
Annual meeting of July 31, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.4%
-
99.7%
Board connections
7 of this board's directors also sit on 12 other boards. 11 are in the same sector.
-
Eloxx Pharmaceuticals Inc. Same sectorvia Geno J. Germano and Steven D. Rubin
-
IceCure Medical Ltd. Same sectorvia Ron Mayron and Yonatan Malca
-
Cocrystal Pharma Inc. Same sectorvia Steven D. Rubin
-
Harmony Biosciences Holdings Inc. Same sectorvia Geno J. Germano
-
Journey Medical Corporation Same sectorvia Miranda Jayne Toledano
-
NexGel Inc Same sectorvia Miranda Jayne Toledano
-
Niagen Bioscience Inc. Same sectorvia Steven D. Rubin
-
OPKO Health Inc. Same sectorvia Steven D. Rubin
-
Precision BioSciences Inc. Same sectorvia Geno J. Germano
-
Protara Therapeutics Inc. Same sectorvia Roger Garceau
- via Steven D. Rubin
-
Teva Pharmaceutical Industries Limited Same sectorvia Gerald M. Lieberman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $140,880
- 8 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Sean Ellis Director | Grant or award | +20,034 | — | — |
| Aug 7, 2026 | Geno J. Germano Director | Grant or award | +25,014 | — | — |
| Aug 7, 2026 | Haya Taitel Director | Grant or award | +20,790 | — | — |
| Aug 7, 2026 | Yonatan Malca Director | Grant or award | +22,815 | — | — |
| Aug 7, 2026 | Steven D. Rubin Director | Grant or award | +19,117 | — | — |
| Jul 14, 2026 | Miranda Jayne Toledano Director, Officer (Chief Executive Officer) | Grant or award | +347,567 | — | — |
| Jul 14, 2026 | Miranda Jayne Toledano Director, Officer (Chief Executive Officer) | Grant or award | +72,993 | — | — |
| May 7, 2026 | Galitzer Hillel Officer (Chief Operating Officer) | Grant or award | +72,993 | — | — |
| May 7, 2026 | Yaacov-Garbeli Dana Officer (Chief Financial Officer) | Grant or award | +58,394 | — | — |
| May 7, 2026 | Burshtein Gregory Officer (Chief of R&D) | Grant or award | +87,591 | — | — |
| Mar 9, 2026 | Geno J. Germano Director | Open-market purchase | +20,000 | $1.30 | $26,000 |
| Mar 5, 2026 | Sean Ellis Director | Open-market purchase | +10,000 | $1.23 | $12,300 |
| Feb 12, 2026 | Steven D. Rubin Director | Open-market purchase | +5,000 | $1.49 | $7,450 |
| Feb 10, 2026 | Haya Taitel Director | Open-market purchase | +7,500 | $1.48 | $11,100 |
| Feb 10, 2026 | Geno J. Germano Director | Open-market purchase | +20,000 | $1.49 | $29,800 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Entera Bio Ltd.
Who is the CEO of Entera Bio Ltd.?
Miranda Jayne Toledano is Entera Bio Ltd.'s Chief Executive Officer.
How many directors are on Entera Bio Ltd.'s board?
Entera Bio Ltd.'s board has 10 directors: Geno J. Germano, Gerald M. Lieberman, Gerald M. Ostrov, Haya Taitel, Miranda Jayne Toledano, Roger Garceau, Ron Mayron, Sean Ellis, Steven D. Rubin and Yonatan Malca.
Are Entera Bio Ltd. insiders buying or selling shares?
Over the last 12 months, Entera Bio Ltd. insiders bought $140,880 of shares in 8 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="entera-bio-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.